Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Events Partner Content SMi's 9th annual Biosimilars & Biobetters Biosimilars & Biobetters conference information
Partner Content Partner Content Agenda Released for USA Biosimilars Conference this November Agenda Released for USA Biosimilars Conference this Nov
Partner Content Partner Content Industry experts set to transform evolving pre-approval & un... Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
